Geoffrey F. Cox, Director at NABI BIOPHARMACEUTICALS (NABI), bought 1,908 shares at $5.24 ($10K) on 2010-05-20, disclosed to the SEC on 2010-05-24.
Open-market purchase of $10k NABI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GTCB | BUY | 2007-12-14 | $10K | — | Filing → |
| GTCB | BUY | 2007-08-13 | $15K | — | Filing → |
| GTCB | BUY | 2007-03-14 | $24K | — | Filing → |